New York State Dormitory Authority The New School University; Private Coll/Univ - General Obligation Sep 11

  • ID: 1922279
  • September 2011
  • Region: New York
  • Standard & Poors
1 of 3

Standard & Poor's Ratings Services assigned its 'A-' long-term rating to New York State Dormitory Authority's series 2011 bonds, issued for The New School University. At the same time, Standard & Poor's affirmed its 'A-' long-term rating on the series 2010 bonds issued for The New School. The outlook is stable. The 'A-' rating reflects our assessment of The New School's: Conservative budgeting resulting in consistent operating surpluses based on generally accepted accounting principles (GAAP), including a $13.8 million operating surplus in fiscal 2010 and a surplus expected for fiscal 2011; Strong demand characteristics for a self-selective, arts-focused institution with an undergraduate acceptance rate of 63% and a 36% matriculation rate for fall 2010; Growing headcount enrollment with an increase...

Companies mentioned in this report are:
- The New School
- Dorm Auth of the St of New York

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

- The New School
- Dorm Auth of the St of New York

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.